vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and ENCORE CAPITAL GROUP INC (ECPG). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $473.6M, roughly 1.8× ENCORE CAPITAL GROUP INC). ENCORE CAPITAL GROUP INC runs the higher net margin — 16.2% vs 0.5%, a 15.6% gap on every dollar of revenue. On growth, ENCORE CAPITAL GROUP INC posted the faster year-over-year revenue change (78.3% vs 7.5%). Over the past eight quarters, ENCORE CAPITAL GROUP INC's revenue compounded faster (20.1% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Encore Capital Group, Inc. is a publicly traded debt buyer based in the United States. The company is headquartered in San Diego, and operates throughout the United States. The firm is a publicly traded NASDAQ Global Select company (ECPG), a component stock of the Russell 2000, the S&P SmallCap 600, and the Wilshire 4500.
ACHC vs ECPG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $473.6M |
| Net Profit | $4.5M | $76.7M |
| Gross Margin | — | — |
| Operating Margin | — | 36.6% |
| Net Margin | 0.5% | 16.2% |
| Revenue YoY | 7.5% | 78.3% |
| Net Profit YoY | -50.8% | — |
| EPS (diluted) | $0.05 | $3.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $473.6M | ||
| Q3 25 | $851.6M | $460.4M | ||
| Q2 25 | $869.2M | $442.1M | ||
| Q1 25 | $770.5M | $392.8M | ||
| Q4 24 | $774.2M | $265.6M | ||
| Q3 24 | $815.6M | $367.1M | ||
| Q2 24 | $796.0M | $355.3M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $76.7M | ||
| Q3 25 | $36.2M | $74.7M | ||
| Q2 25 | $30.1M | $58.7M | ||
| Q1 25 | $8.4M | $46.8M | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $68.1M | $30.6M | ||
| Q2 24 | $78.5M | $32.2M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 36.6% | ||
| Q3 25 | 4.7% | 37.6% | ||
| Q2 25 | 5.8% | 34.1% | ||
| Q1 25 | 1.7% | 32.9% | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 12.1% | 28.9% | ||
| Q2 24 | 13.4% | 28.7% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 16.2% | ||
| Q3 25 | 4.3% | 16.2% | ||
| Q2 25 | 3.5% | 13.3% | ||
| Q1 25 | 1.1% | 11.9% | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 8.4% | 8.3% | ||
| Q2 24 | 9.9% | 9.1% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $3.32 | ||
| Q3 25 | $0.40 | $3.17 | ||
| Q2 25 | $0.33 | $2.49 | ||
| Q1 25 | $0.09 | $1.93 | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.74 | $1.26 | ||
| Q2 24 | $0.85 | $1.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $156.8M |
| Total DebtLower is stronger | $2.5B | $4.0B |
| Stockholders' EquityBook value | $2.0B | $976.8M |
| Total Assets | $5.5B | $5.3B |
| Debt / EquityLower = less leverage | 1.29× | 4.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $156.8M | ||
| Q3 25 | $118.7M | $172.5M | ||
| Q2 25 | $131.4M | $172.9M | ||
| Q1 25 | $91.2M | $187.1M | ||
| Q4 24 | $76.3M | $199.9M | ||
| Q3 24 | $82.1M | $247.4M | ||
| Q2 24 | $77.2M | $250.6M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $4.0B | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | $3.7B | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $976.8M | ||
| Q3 25 | $3.1B | $952.9M | ||
| Q2 25 | $3.1B | $896.0M | ||
| Q1 25 | $3.0B | $819.1M | ||
| Q4 24 | $3.1B | $767.3M | ||
| Q3 24 | $3.0B | $1.0B | ||
| Q2 24 | $3.0B | $988.1M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $5.3B | ||
| Q3 25 | $6.4B | $5.3B | ||
| Q2 25 | $6.3B | $5.2B | ||
| Q1 25 | $6.1B | $5.0B | ||
| Q4 24 | $6.0B | $4.8B | ||
| Q3 24 | $5.9B | $5.0B | ||
| Q2 24 | $5.7B | $4.8B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 4.13× | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | 4.83× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $153.2M |
| Free Cash FlowOCF − Capex | — | $126.9M |
| FCF MarginFCF / Revenue | — | 26.8% |
| Capex IntensityCapex / Revenue | — | 5.5% |
| Cash ConversionOCF / Net Profit | 13.78× | 2.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $244.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $153.2M | ||
| Q3 25 | $73.2M | $81.6M | ||
| Q2 25 | $133.5M | $9.5M | ||
| Q1 25 | $11.5M | $45.3M | ||
| Q4 24 | $116.7M | $156.2M | ||
| Q3 24 | $163.1M | $45.9M | ||
| Q2 24 | $171.1M | $35.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $126.9M | ||
| Q3 25 | $-63.0M | $75.6M | ||
| Q2 25 | $-34.2M | $3.2M | ||
| Q1 25 | $-163.2M | $38.3M | ||
| Q4 24 | $-86.8M | $127.2M | ||
| Q3 24 | $-27.1M | $39.7M | ||
| Q2 24 | $16.9M | $28.3M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 26.8% | ||
| Q3 25 | -7.4% | 16.4% | ||
| Q2 25 | -3.9% | 0.7% | ||
| Q1 25 | -21.2% | 9.7% | ||
| Q4 24 | -11.2% | 47.9% | ||
| Q3 24 | -3.3% | 10.8% | ||
| Q2 24 | 2.1% | 8.0% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 5.5% | ||
| Q3 25 | 16.0% | 1.3% | ||
| Q2 25 | 19.3% | 1.4% | ||
| Q1 25 | 22.7% | 1.8% | ||
| Q4 24 | 26.3% | 10.9% | ||
| Q3 24 | 23.3% | 1.7% | ||
| Q2 24 | 19.4% | 2.1% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.00× | ||
| Q3 25 | 2.02× | 1.09× | ||
| Q2 25 | 4.43× | 0.16× | ||
| Q1 25 | 1.37× | 0.97× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 1.50× | ||
| Q2 24 | 2.18× | 1.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
ECPG
Segment breakdown not available.
